HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Moriya Selected Research

Carrier Proteins (Binding Protein)

10/2021Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis.
10/2020Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy.
8/2020Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.
9/2017Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Moriya Research Topics

Disease

39Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 07/2008
34Fibrosis (Cirrhosis)
05/2022 - 12/2008
15Hepatocellular Carcinoma (Hepatoma)
10/2021 - 07/2008
12Neoplasms (Cancer)
01/2021 - 02/2007
11Fatty Liver
12/2021 - 07/2013
8Non-alcoholic Fatty Liver Disease
11/2021 - 02/2016
7Liver Diseases (Liver Disease)
10/2021 - 05/2013
6Hepatic Encephalopathy
12/2021 - 07/2003
6Alcoholic Fatty Liver
03/2019 - 07/2008
5Infections
01/2022 - 05/2013
5Inflammation (Inflammations)
12/2021 - 01/2013
5Insulin Resistance
08/2020 - 08/2013
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2021 - 01/2013
4Body Weight (Weight, Body)
01/2021 - 02/2007
4Hyperammonemia
12/2020 - 12/2017
3Ascites
05/2022 - 08/2017
3Thrombophilia
03/2022 - 05/2019
3Sarcopenia
03/2022 - 01/2020
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 01/2017
3Muscle Cramp (Cramp)
12/2020 - 01/2019
3Chronic Hepatitis (Chronic Active Hepatitis)
01/2019 - 01/2018
2Acute-On-Chronic Liver Failure
04/2022 - 05/2020
2Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
09/2021 - 07/2021
2Dysbiosis
06/2021 - 01/2019
2Cognitive Dysfunction
06/2021 - 03/2020
2Lymphoma (Lymphomas)
01/2021 - 07/2012
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2018
2Cholangiocarcinoma
10/2020 - 10/2018
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 01/2019
2Thrombosis (Thrombus)
09/2020 - 08/2017
2Thrombocytopenia (Thrombopenia)
09/2020 - 01/2020
2Hemorrhage
09/2020 - 01/2017
2Chronic Hepatitis B
08/2020 - 09/2017
2Hypertension (High Blood Pressure)
06/2020 - 11/2017
2Pathologic Constriction (Stenosis)
06/2020 - 01/2018
2Endotoxemia
03/2020 - 12/2017
2Carcinogenesis
03/2020 - 11/2017

Drug/Important Bio-Agent (IBA)

13EndotoxinsIBA
05/2022 - 01/2013
9Biomarkers (Surrogate Marker)IBA
04/2022 - 09/2017
9Amino AcidsFDA Link
09/2021 - 07/2013
8CollagenIBA
10/2020 - 12/2008
7von Willebrand FactorIBA
04/2022 - 02/2018
7LipopolysaccharidesIBA
01/2022 - 08/2017
7CDAA (Randox)IBA
12/2021 - 07/2013
7Choline (Choline Chloride)IBA
03/2020 - 07/2013
6Losartan (Cozaar)FDA LinkGeneric
01/2022 - 11/2017
6Angiotensin II Type 1 Receptor BlockersIBA
01/2022 - 02/2016
5EnzymesIBA
04/2022 - 11/2013
5Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2022 - 02/2016
5Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 05/2013
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 09/2017
5CytokinesIBA
06/2021 - 01/2013
5Glucose (Dextrose)FDA LinkGeneric
03/2020 - 11/2017
4Toll-Like Receptor 4IBA
01/2022 - 06/2019
4Rifaximin (L 105)FDA Link
12/2021 - 12/2017
4Carbon Tetrachloride (Tetrachloromethane)IBA
12/2021 - 12/2008
4Angiotensin IIIBA
12/2021 - 04/2013
4Angiotensin Receptor AntagonistsIBA
12/2021 - 10/2014
4Carrier Proteins (Binding Protein)IBA
10/2021 - 09/2017
4Prednisolone (Predate)FDA LinkGeneric
01/2021 - 10/2008
4Glutathione Transferase (Glutathione S-Transferase)IBA
06/2018 - 12/2008
3TolvaptanFDA Link
05/2022 - 08/2017
3AntigensIBA
04/2022 - 12/2020
3ZincIBA
03/2022 - 06/2021
3AmmoniaIBA
03/2022 - 07/2003
3Bile Acids and Salts (Bile Acids)IBA
01/2022 - 11/2017
3Ethanol (Ethyl Alcohol)IBA
12/2021 - 09/2007
3Branched-Chain Amino AcidsIBA
12/2021 - 08/2013
3Tissue Inhibitor of MetalloproteinasesIBA
10/2021 - 08/2020
3Hyaluronic Acid (Hyaluronan)IBA
10/2021 - 08/2020
3AntioxidantsIBA
06/2021 - 12/2020
3Proteins (Proteins, Gene)FDA Link
06/2021 - 10/2018
3DiureticsIBA
01/2021 - 08/2017
3Alanine Transaminase (SGPT)IBA
04/2020 - 09/2017
3Sorafenib (BAY 43-9006)FDA Link
12/2019 - 10/2014
2AlbuminsIBA
10/2021 - 09/2019
2Collagen Type III (Type III Collagen)IBA
10/2021 - 08/2020
2Triglycerides (Triacylglycerol)IBA
09/2021 - 06/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2021 - 06/2020
2Capsules (Microcapsules)IBA
01/2021 - 01/2017
2SteroidsIBA
01/2021 - 10/2008
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 07/2008
2lenvatinibIBA
01/2021 - 01/2021
2Messenger RNA (mRNA)IBA
01/2021 - 11/2017
2Therapeutic UsesIBA
12/2020 - 11/2017
2Carnitine (L-Carnitine)FDA LinkGeneric
12/2020 - 01/2019
2procollagen Type III-N-terminal peptide (PIIP)IBA
10/2020 - 08/2020
2lusutrombopagIBA
09/2020 - 01/2020
2Antiviral Agents (Antivirals)IBA
08/2020 - 01/2019
2Insulin (Novolin)FDA Link
04/2020 - 09/2019
2CanagliflozinIBA
03/2020 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 05/2019
2Metalloproteases (Metalloproteinases)IBA
05/2019 - 12/2008
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2019 - 01/2013

Therapy/Procedure

14Therapeutics
05/2022 - 10/2008
7Drug Therapy (Chemotherapy)
01/2021 - 08/2018
6Oral Administration
01/2021 - 01/2018
3Intraperitoneal Injections
01/2021 - 01/2019
3Transplantation
01/2009 - 12/2008
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2009 - 12/2008